Cargando…
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease
The safety and efficacy of lentivirus-mediated gene therapy was recently demonstrated in five male patients with Fabry disease—a rare X-linked lysosomal storage disorder caused by GLA gene mutations that result in multiple end-organ complications. To evaluate the risks of clonal dominance and leukem...
Autores principales: | Saleh, Amr H., Rothe, Michael, Barber, Dwayne L., McKillop, William M., Fraser, Graeme, Morel, Chantal F., Schambach, Axel, Auray-Blais, Christiane, West, Michael L., Khan, Aneal, Fowler, Daniel H., Rupar, C. Anthony, Foley, Ronan, Medin, Jeffrey A., Keating, Armand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932294/ https://www.ncbi.nlm.nih.gov/pubmed/36816757 http://dx.doi.org/10.1016/j.omtm.2023.01.003 |
Ejemplares similares
-
Lentivirus-mediated gene therapy for Fabry disease
por: Khan, Aneal, et al.
Publicado: (2021) -
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34(+) Cells for Correction of Fabry Disease
por: Huang, Ju, et al.
Publicado: (2017) -
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
por: Nagree, Murtaza S, et al.
Publicado: (2022) -
Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction
por: Yogasundaram, Haran, et al.
Publicado: (2018) -
Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion
por: Kamani, Mustafa A, et al.
Publicado: (2016)